Chicago Med is a U.S. television program aired on NBC since Tuesday, November 17, 2015. Chicago Med is currently the third most popular show on NBC and fifth overall on TV, watched by a total number of 6,599,000 people (2.11% rating, up +97% from last week) as of the daily audience measurement on .
Demographic breakdown of the most recent historical ratings of Chicago Med on NBC as of Wednesday, March 22, 2023.
| Chicago Med Daily Ratings | |||
|---|---|---|---|
| Date | Demo | Audience | Rating |
| 2023-Mar-22 | HH | 4,985,000 | 4.00 |
| P2+ | 6,599,000 | 2.11 | |
| P18-49 | 628,000 | 0.48 | |
| P25-54 | 972,600 | 0.80 | |
| 2023-Mar-15 R | P2+ | 3,355,000 | 1.07 |
| P18-49 | 378,500 | 0.29 | |
| P25-54 | 595,700 | 0.49 | |
| 2023-Mar-08 R | P2+ | 3,671,000 | 1.18 |
| P18-49 | 352,400 | 0.27 | |
| P25-54 | 547,100 | 0.45 | |
| 2023-Mar-01 | P2+ | 6,569,000 | 2.10 |
| P18-49 | 770,000 | 0.59 | |
| P25-54 | 1,179,200 | 0.97 | |
| 2023-Feb-22 | P2+ | 6,515,000 | 2.09 |
| P18-49 | 796,100 | 0.61 | |
| P25-54 | 1,191,400 | 0.98 | |
| 2023-Feb-15 | P2+ | 6,736,000 | 2.16 |
| P18-49 | 809,200 | 0.62 | |
| P25-54 | 1,154,900 | 0.95 | |
| 2023-Feb-08 R | P2+ | 3,396,000 | 1.09 |
| P18-49 | 391,500 | 0.30 | |
| P25-54 | 559,200 | 0.46 | |
| 2023-Feb-01 R | HH | 3,038,000 | 2.50 |
| P2+ | 3,837,000 | 1.23 | |
| P18-49 | 493,000 | 0.38 | |
| P25-54 | 692,900 | 0.57 | |
| 2023-Jan-25 R | HH | 3,116,000 | 2.50 |
| P2+ | 3,969,000 | 1.27 | |
| P18-49 | 451,000 | 0.35 | |
| P25-54 | 680,800 | 0.56 | |
| 2023-Jan-18 | HH | 5,230,000 | 4.20 |
| P2+ | 6,949,000 | 2.23 | |
| P18-49 | 847,000 | 0.65 | |
| P25-54 | 1,240,000 | 1.02 | |
| 2023-Jan-11 | HH | 5,167,000 | 4.20 |
| P2+ | 6,798,000 | 2.18 | |
| P18-49 | 811,000 | 0.62 | |
| P25-54 | 1,191,400 | 0.98 | |
| 2023-Jan-04 | P2+ | 6,755,000 | 2.16 |
| P18-49 | 822,200 | 0.63 | |
| P25-54 | 1,167,100 | 0.96 | |
| 2022-Dec-07 | HH | 5,078,000 | 4.10 |
| P2+ | 6,642,000 | 2.13 | |
| P18-49 | 803,000 | 0.62 | |
| P25-54 | 1,227,900 | 1.01 | |
| 2022-Nov-16 | HH | 5,282,000 | 4.30 |
| P2+ | 6,727,000 | 2.15 | |
| P18-49 | 770,000 | 0.59 | |
| P25-54 | 1,215,700 | 1.00 | |
| 2022-Nov-09 | HH | 4,643,000 | 3.80 |
| P2+ | 6,034,000 | 1.93 | |
| P18-49 | 752,000 | 0.58 | |
| P25-54 | 1,094,100 | 0.90 | |
| 2022-Nov-02 | HH | 5,178,000 | 4.20 |
| P2+ | 6,580,000 | 2.11 | |
| P18-49 | 750,000 | 0.57 | |
| P25-54 | 1,069,800 | 0.88 | |
| 2022-Oct-26 R/ RP | HH | 3,133,000 | 2.60 |
| P2+ | 4,106,000 | 1.32 | |
| P18-49 | 418,000 | 0.32 | |
| P25-54 | 620,500 | 0.51 | |
| 2022-Oct-19 | HH | 5,292,000 | 4.30 |
| P2+ | 6,876,000 | 2.21 | |
| P18-49 | 839,000 | 0.64 | |
| P25-54 | 1,228,900 | 1.01 | |
| 2022-Oct-12 | HH | 5,096,000 | 4.20 |
| P2+ | 6,575,000 | 2.11 | |
| P18-49 | 726,000 | 0.56 | |
| P25-54 | 1,119,400 | 0.92 | |
| 2022-Oct-05 | P2+ | 6,747,000 | 2.17 |
| P18-49 | 834,900 | 0.64 | |
| P25-54 | 1,314,000 | 1.08 | |